Researcher
Peter Covens
- Research Expertise:
Nuclear medicine
- Keywords:General and logistic services, Medicine
- Disciplines:Nuclear engineering, Nuclear imaging, Radiation therapy
- Users of research expertise:
Nuclear medicine
Affiliations
- Medical Imaging (Research group)
Member
From20 Oct 2010 → Today - UZB Other (Department)
Member
From1 Jan 2008 → Today - Supporting clinical sciences (Department)
Member
From1 Oct 2020 → Today - Supporting clinical sciences (Department)
Member
From1 Oct 2020 → 20 Oct 2022 - Preventie- & Milieudienst (Administrative office)
Member
From1 Dec 2018 → 30 Nov 2020 - Preventie- & Milieudienst (Administrative office)
Member
From1 Nov 2012 → 31 Dec 2016 - Translational Radiation Oncology and Physics (Research group)
Member
From20 Oct 2010 → 13 Sep 2013
Projects
1 - 2 of 2
- Exploiting Peptides as Protein Binders, Modulators, Inhibitors and Biomaterials for Imaging and Therapy [Exploit-PeptIT]From1 Mar 2024 → TodayFunding: BOF - projects
- EURALOC - OPERRA -Open Project for the European Radiation Research AreaFrom1 Jun 2013 → 31 May 2017Funding: Nuclear Fission and Radiation Protection
Publications
1 - 10 of 26
- Joint EURADOS-EANM initiative for an advanced computational framework for the assessment of external dose rates from nuclear medicine patients(2024)
Authors: Lara Struelens, Christelle Huet, David Broggio, Jérémie Dabin, Laurent Desorgher, Augusto Giussani, Wei Bo Li, Dietmar Nosske, Yi-Kang Lee, Lidia Cunha, et al.
- Optimized cyclotron production of 211At: The challenge of 210Po-characterization(2023)
Authors: Matthijs Sevenois, Brian WM Miller, Holger Jan Jensen, Matthias D'Huyvetter, Peter Covens
- Optimizing the Safety and Efficacy of Bio-Radiopharmaceuticals for Cancer Therapy(2023)
Authors: Cyprine Neba Funeh, Nick Devoogdt, Dora Mugoli Chigoho, Timo W M De Groof, Jessica Bridoux, Thomas Ertveldt, Peter Covens, Matthias D'Huyvetter
- A realistic multiregion mouse kidney dosimetry model to support the preclinical evaluation of potential nephrotoxicity of radiopharmaceutical therapy(2023)
Authors: Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, Vicky Caveliers, Peter Covens
Pages: 493-499 - Extremity exposure of nuclear medicine workers(2023)
Authors: Lídia Cunha, Jérémie Dabin, Sigrid Leide-Svegborn, Alessandra Zorz, Robert Kollaard, Peter Covens
Pages: 29-36 - Finger doses due to Ga-68-labelled pharmaceuticals in PET departments-results of a multi-centre pilot study(2023)
Authors: Ann McCann, Nicolas Cherbuin, Peter Covens, Jérémie Dabin, Sigalit Haruz-Waschitz, Lara Gallo, Hanan Datz, Roel Wierts, Malgorzata Wrzesien, Alessandra Zorz, et al.
- Radiation dosimetry to support the preclinical investigation and further development of radiopharmaceutical therapy(2023)
Authors: Clarita Saldarriaga Vargas, Peter Covens, Vicky Caveliers, Lara Struelens
Number of pages: 168 - Preclinical evaluation of 225Ac-labeled single-domain antibody for the treatment of HER2pos cancer(2022)
Authors: Magdalena Rodak, Yana Dekempeneer, Maria Wojewódzka, Vicky Caveliers, Peter Covens, Brian W Miller, Matthijs Sevenois, Frank Bruchertseifer, Alfred Morgenstern, Tony Lahoutte, et al.
Pages: 1835-1845 - Assessment of mouse-specific pharmacokinetics in kidneys based on I-131 activity measurements using micro-SPECT(2022)
Authors: Clarita Saldarriaga Vargas, Lara Struelens, Matthias D'Huyvetter, Vicky Caveliers, Peter Covens
Pages: 13 - Review of extremity dosimetry in nuclear medicine(2021)
Authors: Robert Kollaard, Alessandra Zorz, Jérémie Dabin, Peter Covens, Jennie Cooke, Melissa Crabbé, Lidia Cunha, Anita Dowling, Merce Ginjaume, Leanne McNamara
Pages: R60-R87